Kuo, Cheng-YenCheng-YenKuoTsai, Wei-ChunWei-ChunTsaiLee, Hui-FengHui-FengLeeHo, Tzong-ShiannTzong-ShiannHoLI-MIN HUANGShen, Ching-FenChing-FenShenLiu, Ching-ChuanChing-ChuanLiu2022-03-312022-03-312021-10-1316841182https://scholars.lib.ntu.edu.tw/handle/123456789/602728Since the global use of the pneumococcal conjugate vaccine, Mycoplasma pneumoniae (MP) has become the most common bacterial cause of lower respiratory tract infections among children. Monitoring the changing epidemiology and antimicrobial resistance rates of this organism is important for MP clinical management.enAntibiotic resistance; Community acquired pneumonia; Macrolides; Mycoplasma pneumoniae[SDGs]SDG3The epidemiology, clinical characteristics, and macrolide susceptibility of Mycoplasma pneumoniae pneumonia in children in Southern Taiwan, 2019-2020journal article10.1016/j.jmii.2021.09.010346885762-s2.0-85118320451https://api.elsevier.com/content/abstract/scopus_id/85118320451